PHARMASPIRE - Volume 13, Issue 2, April - June, 2021
Pages: 42-53
Date of Publication: 07-Jun-2022
Print Article
Download XML Download PDF
Recent advances in the medicinal chemistry of tetrazole as antibacterial agents: a comprehensive study
Author: Vikrant Rahi , Navneet Kaur , Shubham Kumar, Pinky Arora
Category: Pharmaceutics
Abstract:
Bacterial infections are rapidly increasing world widely and there is a massive increase in incident of invasive bacterial infections in the past two decades. Development of drug resistance bacteria such as multidrug-resistant strains, intractable pathogens, and newly arising pathogenic organisms is increasing the patients with bacterial infections. Tetrazole hybrids, has a wide range of biological activities, can be used as a privileged scaffold for the development of new lead molecule. Tetrazole moiety can be hybridized with other molecules to develop new molecules with potential antibacterial activity. Various tetrazole based molecules have been designed, synthesized and screened for antibacterial activity in recent years. Some of them are possessing promising activity against various Gram-positive as well as Gram-negative bacteria. Tetrazole has various biological activities such as anticancer, antifungal, antiangiogenic, antiviral, antimalarial, antitubercular, and antibacterial and thus, this has prompted the medicinal chemist to design and develop tetrazole based molecule with the desired biological profile. This review summarizes the recent advances and development in medicinal chemistry of tetrazole hybrids for the development of potential antibacterial agent. This review will provide rationale of various researchers to design more effective tetrazole based clinical candidates.
Keywords: Antibacterial activity, biological activity, molecular docking, tetrazole derivatives
References:
1. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010;74:417-33.
2. Tambo-Ong A, Chopra S, Glaser B, Matsuyama K, Tran T, Madrid P. Mannich reaction derivatives of novobiocin with modulated physiochemical properties and their antibacterial activities. Bioorg Med Chem Lett 2011;21:5697-700.
3. Scheffler R, Colmer S, Tynan H, Demain A, Gullo V. Antimicrobials, drug discovery, and genome mining. Appl Microbiol Biotechnol 2012;97:969-78.
4. Genin M, Allwine D, Anderson D, Barbachyn MR, Emmert DE, Garmon SA, et al. Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl) oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella acatarrhalis. J Med Chem 2000;43:953-70.
5. Rani N, Sharma A, Singh R. Imidazoles as promising scaffolds for antibacterial activity: A review. Mini Rev Med Chem 2013;13:1812-35.
6. Shalini K, Kumar N, Drabu S, Sharma P. Advances in synthetic approach to and antifungal activity of triazoles. Beilstein J Org Chem 2011;7:668-77.
7. Wang S, Wang Y, Xu Z. Tetrazole hybrids and their antifungal activities. Eur J Med Chem 2019;170:225-34.
8. Karrouchi K, Radi S, Ramli Y, Taoufik J, Mabkhot YN, Al-Aizari FA, et al. Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules 2018;23:134.
9. Kakkar S, Narasimhan B. A comprehensive review on biological activities of oxazole derivatives. BMC Chem 2019;13:16.
10. Sadek B, Al-Tabakha M, Fahelelbom K. Antimicrobial prospect of newly synthesized 1,3-thiazole derivatives. Molecules 2011;16:9386-96.
11. Zhang L, Peng X, Damu G, Geng R, Zhou C. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med Res Rev 2013;34:340-437.
12. Wei C, Bian M, Gong G. Tetrazolium compounds: Synthesis and applications in medicine. Molecules 2015;20:5528-53.
13. Gao H, Shreeve J. Azole-based energetic salts. Chem Rev 2011;111:7377-36.
14. Lim S, Sunohara Y, Matsumoto H. Action of fentrazamide on protein metabolism and cell division in plants. J Pestic Sci 2007;32:249-54.
15. ?odyga-Chru?ci?ska E. Tetrazole peptides as copper (II) ion chelators. Coord Chem Rev 2011;255:1824-33.
16. He Y, Cai C. Tetrazole functionalized polymer supported palladium complex: An efficient and reusable catalyst for the room-temperature Suzuki cross-coupling reaction. Catal Lett 2010;140:153-9.
17. Zhang H, Gan L, Wang H, Zhou C. New progress in azole compounds as antimicrobial agents. Mini Rev Med Chem 2016;17:122-66.
18. Aziz H, Saeed A, Jabeen F, Din N, Flörke U. Synthesis, single crystal analysis, biological and docking evaluation of tetrazole derivatives. Heliyon 2018;4:e00792.
19. Chen Y, Shoichet B. Molecular docking and ligand specificity in fragment-based inhibitor discovery. Nat Chem Biol 2009;5:358-64.
20. Kumar C, Parida D, Santhoshi A, Kota A, Sridhar B, Rao V. Synthesis and biological evaluation of tetrazole containing compounds as possible anticancer agents. Medchemcomm 2011;2:486.
21. Qian A, Zheng Y, Wang R, Wei J, Cui Y, Cao X, et al. Design, synthesis, and structure-activity relationship studies of novel tetrazole antifungal agents with potent activity, broad antifungal spectrum and high selectivity. Bioorg Med Chem Lett 2018;28:344-50.
22. Zhan P, Liu H, Liu X, Wang Y, Pannecouque C, Witvrouw M, et al. Synthesis and anti-HIV activity evaluation of novel N’-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides. Med Chem Res 2009;19:652-63.
23. Yeung K, Qiu Z, Yang Z, Zadjura L, D’Arienzo CJ, Browning MR, et al. Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative. Bioorg Med Chem Lett 2013;23:209-12.
24. Kalaria P, Karad S, Raval D. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery. Eur J Med Chem 2018;158:917-36.
25. Kushwaha P, Fatima S, Upadhyay A, Gupta S, Bhagwati S, Baghel T, et al. Synthesis, biological evaluation and molecular dynamic simulations of novel benzofuran-tetrazole derivatives as potential agents against Alzheimer’s disease. Bioorg Med Chem Lett 2019;29:66-72.
26. Hameed A, Zehra S, Abbas S, Nisa RU, Mahmood T, Ayub K, et al. One-pot synthesis of tetrazole-1,2,5,6-tetra hydro nicotinonitriles and cholinesterase inhibition: Probing the plausible reaction mechanism via computational studies. Bioorg Chem 2016;65:38-47.
27. Gao C, Chang L, Xu Z, Yan XF, Ding C, Zhao F, et al. Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Eur J Med Chem 2019;163:404-12.
28. Lamie P, Philoppes J, Azouz A, Safwat N. Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: Design, synthesis, antiinflammatory evaluation, ulcerogenic liability and docking study. J Enzyme Inhib Med Chem 2017;32:805-20.
29. Dai L, Zhang H, Nagarajan S, Rasheed S, Zhou C. Synthesis of tetrazole compounds as a novel type of potential antimicrobial agents and their synergistic effects with clinical drugs and interactions with calf thymus DNA. Medchemcomm 2015;6:147-54.
30. Randhawa E, Woytanowski J, Sibliss K, Sheffer I. Streptococcus pyogenes and invasive central nervous system infection. SAGE Open Med Case Rep 2018;6:2050313.
31. Chen S. Genomic insights into the distribution and evolution of Group B Streptococcus. Front Microbiol 2019;10:1447.
32. Waite R, Qureshi M, Whiley R. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus. PLoS One 2017;12:e0173741.
33. Tong S, Davis J, Eichenberger E, Holland T, Fowler V. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015;28:603-61.
34. Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology. Clin Microbiol Rev 2018;31:18.
35. Ramos-Silva P, Serrano M, Henriques A. From root to tips: Sporulation evolution and specialization in Bacillus subtilis and the intestinal pathogen clostridioides difficile. Mol Biol Evol 2019;36:2714-36.
36. Thakur N, Jain S, Changotra H, Shrivastava R, Kumar Y, Grover N, et al. Molecular characterization of diarrheagenic Escherichia coli patho types: Association of virulent genes, serogroups, and antibiotic resistance among moderate-to-severe diarrhea patients. J Clin Lab Anal 2018;32:e22388.
37. Bolocan AS, Upadrasta A, de Almeida Bettio PH, Clooney AG, Draper LA, Ross RP, et al. Evaluation of phage therapy in the context of Enterococcus faecalis and its associated diseases. Viruses 2019;11:366.
38. Neu H. Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 1974;6:177-82.
39. Yotsuji A, Mitsuyama J, Hori R, Yasuda T, Saikawa I, Inoue M, et al. Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis. Antimicrob Agents Chemother 1988;32:1848-53.
40. Ferrández O, Urbina O, Grau S. Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections. Drug Des Devel Ther 2016;11:65-82.
41. Hosoya T, Kuriyama S, Yoshizawa T, Kobayashi A, Otsuka Y, Ohno I. Effects of combined antihypertensive therapy with losartan/hydrochlorothiazide on uric acid metabolism. Intern Med 2012;51:2509-14.
42. Giles T, Cockcroft J, Pitt B, Jakate A, Wright H. Rationale for nebivolol/ valsartan combination for hypertension. J Hypertens 2017;35:1758-67.
43. Ashok D, Nagaraju N, Lakshmi B, Sarasija M. Microwave assisted synthesis of 5-[4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)phenyl]-1H-tetrazole derivatives and their antimicrobial activity. Russ J Gen Chem 2019;89:1905-10.
44. Abu-Hashem A, El-Shazly M. Synthesis and antimicrobial evaluation of novel triazole, tetrazole, and spiropyrimidine-thiadiazole derivatives. Polycycl Aromat Comp 2019;41:1-20.
45. Sathe BP, Phatak PS, Rehman NN, Dixit PP, Khed-Kar VM, Vedpathak SG, et al. Synthesis, anti-microbial evaluation and molecular docking studies of some novel tetrazole containing azodye derivatives. Chem Bio Inter 2019;9:96-113.
46. Özkan H, Demirci B. Synthesis and antimicrobial and antioxidant activities of sulfonamide derivatives containing tetrazole and oxadiazole rings. J Heterocycl Chem 2019;56:2528-35.
47. Bahrin L, Clima L, Shova S, Rosca I, Cojocaru C, Bejan D, et al. Synthesis, structure, computational modeling, and biological activity of two novel bimesitylene derivatives. Res Chem Intermed 2018;45:453-69.
48. Andrejevi? T, Nikoli? A, Gliši? B, Wadepohl H, Vojnovic S, Zlatovi? M, et al. Synthesis, structural characterization and antimicrobial activity of silver(I) complexes with 1-benzyl-1H-tetrazoles. Polyhedron 2018;154:325-33.
49. Sribalan R, Banuppriya G, Kirubavathi M, Padmini V. Synthesis, biological evaluation and in silico studies of tetrazole-heterocycle hybrids. J Mol Struct 2019;1175:577-86.
50. Szulczyk D, Dobrowolski M, Roszkowski P, Bielenica A, Stefa?ska J, Koli?ski M, et al. Design and synthesis of novel 1H-tetrazol-5-amine based potent antimicrobial agents: DNA topoisomerase IV and gyrase affinity evaluation supported by molecular docking studies. Eur J Med Chem 2018;156:631-40.
51. Myznikov L, Hrabalek A, Koldobskii G. Drugs in the tetrazole series. Chem Inform 2007;38:42264.
52. Rajasekaran A, Thampi P. Synthesis and analgesic evaluation of some 5-[β-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-tetrazoles. Eur J Med Chem 2004;39:273-9.
53. Uchida M, Komatsu M, Morita S, Kanbe T, Yamasaki K, Nakagawa K. Studies on gastric antiulcer active agents. III. Synthesis of 1-substituted 4-(5-tetrazolyl) thio-1-butanones and related compounds. Chem Pharm Bull 1989;37:958-61.
54. Soliman H, Kalmouch A, Awad H, Wahed NA. Synthesis of new tetrazole derivatives and their biological evaluation. Russ J Gen Chem 2018;88:1726-33.
55. Khan F, Zaheer Z, Sangshetti J, Ahmed R. Facile one-pot synthesis, antibacterial activity and in silico ADME prediction of 1-substituted-1 H -1,2,3,4-tetrazoles. Chem Data Coll 2018;15-16:107-14.
56. Baghershiroudi M, Safa K, Adibkia K, Lotfipour F. Synthesis and antibacterial evaluation of new sulfanyltetrazole derivatives bearing piperidine dithiocarbamate moiety. Synth Commun 2018;48:323-8.
57. Baghershiroudi M, Safa K, Adibkia K, Lotfipour F. Bulky organosilicon compounds based on sulfanyltetrazoles: Their synthesis and in vitro antibacterial evaluation. J Iran Chem Soc 2018;15:1279-86.
58. Kumbar M, Kamble R, Dasappa J, Bayannavar PK, Khamees HA, Mahendra M, et al. 5-(1-Aryl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)-1H-tetrazoles: Synthesis, structural characterization, hirshfeld analysis, anti-inflammatory and antibacterial studies. J Mol Struct 2018;1160:63-72.
59. Srinivas B, Kumar P, Reddy PN, Venu S, Shyam P, Krupadanam GD. Design, synthesis, antioxidant and antibacterial activities of novel 2-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-5-(2HChromen-3-yl)-2H-tetrazoles. Russ J Bioorg Chem 2018;44:244-51.
60. Dileep K, Polepalli S, Jain N, Buddana S, Prakasham R, Murty M. Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity. Mol Divers 2017;22:83-93.
61. Dofe V, Sarkate A, Shaikh Z, Gill C. Ultrasound-assisted synthesis and antimicrobial activity of tetrazole-based pyrazole and pyrimidine derivatives. Heterocycl Commun 2018;24:59-65.
|
